A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

‘Brand kānuka’ could be a unique NZ industry
Primary Sector

‘Brand kānuka’ could be a unique NZ industry

Kānuka properties differ from its better-known cousin mānuka.

Greg Hurrell 25 Mar 2025
Will this solution make burgers less bad for the planet?
Primary Sector

Will this solution make burgers less bad for the planet?

Gene editing may be the answer to cutting cows' methane output.